|Events|January 20, 2023

Drug Pricing Transparency Congress (5/16 - 5/17/23)

Stay on the Pulse of Federal and State Reporting Requirements, Policy Initiatives & Strategic Best Practices for Compliance

Discuss how current and future drug pricing transparency regulations will impact commercialization, reimbursement, pricing and compliance practices. Assess how companies are planning internally for these changes, hear updates impacting drug pricing transparency and gain a preview of what’s to come.


Related to this article

Pharmaceutical Executive Daily
FDA reportedly shelves its Commissioner’s National Priority Voucher program, Eli Lilly breaks ground on a $3.5 billion Pennsylvania manufacturing site for next-generation obesity treatments, and Parexel’s Stacy Hurt on how small protocol decisions can become enrollment and retention barriers.